Clinical trial Recruiting at 3 sites Interventional Ages 18 to 80

Evaluating a device to help patients with motor disabilities control external equipment

Official title: A Prospective Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability

Run by Neuracle Medical Technology(Shanghai) Co.,Ltd. · NCT05920174 · Data updated 2026-11-12

This study is testing a new device that helps people with motor disabilities, like tetraplegia, control things like wheelchairs and robotic arms using their brain signals.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment9 (estimated)
SponsorNeuracle Medical Technology(Shanghai) Co.,Ltd.
Industry-sponsored
Locations4 sites (Beijing, Beijing Municipality and 3 other locations)
StatusRecruiting
StartedOctober 17, 2023
Main results expectedDecember 2024
Study endsDecember 2025
Registry record updatedDecember 5, 2024
Trial IDNCT05920174 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 to 80 with stable complete or incomplete quadriplegia due to spinal cord injury, brain stem stroke, or motor neuron disorders.

Probably not a fit

Patients with progressive neurological diseases or significant visual impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess the safety and efficacy of an implantable neural acquisitor and stimulator system designed for patients with motor disabilities, specifically those with tetraplegia. Utilizing brain-computer interface technology, the system allows patients to control external devices such as wheelchairs and robotic arms using their brain signals. The study will include patients diagnosed with complete or incomplete quadriplegia due to various neurological conditions, ensuring they have a functional brain motor-related cortex. Participants will be monitored for their ability to use the device effectively and safely over the course of the trial.

Why it matters

Potential benefit: If successful, this technology could significantly enhance the quality of life for patients with motor disabilities by providing them greater independence and control over their environment.

How similar studies have gone: While the approach of using brain-computer interfaces is gaining traction, this specific application in motor disabilities is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged between 18 and 80 years of age;
2. Complete or incomplete quadriplegia due to spinal cord injury, brain stem stroke, amyotrophic lateral sclerosis and other motor neuron disorders;
3. After the neurological assessment, the brain motor-related cortex is functional, and there is no obvious organic disease or functional disease;
4. The above diseases have been diagnosed for at least 12 months and stable for at least 6 months after standard treatment;
5. The patient had normal cognitive function, good compliance and volunteered to participate in the clinical trial.

Exclusion Criteria:

1. Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses;
2. Combined with progressive neurological disease;
3. Combined with surgical contraindications identified by surgeons and anesthesiologists;
4. Participating in other clinical trials;
5. Other conditions deemed inappropriate by investigators and medical staff.

Where it's running

  • Xuanwu Hospital,Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting
  • Beijing Tiantan Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting
  • Huashan Hospital Affiliated to Fudan University
    Shanghai, Shanghai Municipality, China
    Recruiting
  • Chinese PLA General Hospital
    Beijing, Beijing Municipality, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.